NCT04163692 (PREBCA) is a NA clinical trial of Progressive relaxation exercises in Breast Cancer, sponsored by Hacettepe University.

Who is sponsoring NCT04163692?

NCT04163692 is sponsored by Hacettepe University.

What drugs are being tested in NCT04163692?

Interventions in NCT04163692: Progressive relaxation exercises.

What condition does NCT04163692 study?

NCT04163692 studies Breast Cancer.

Is NCT04163692 still recruiting?

NCT04163692 is currently completed. Last updated 1 April 2021.

Last reviewed 2021-04-01 · How we verify

NCT04163692: PREBCA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Progressive Relaxation Training in Breast Cancer Patients Receiving Aromatatase Inhibitor Therapy

Completed NA Last updated 1 April 2021

What this trial tests

NA trial testing Progressive relaxation exercises in Breast Cancer in 44 participants. Completed in 24 September 2020.

Timeline

25 October 2019

Primary endpoint
24 September 2020

24 September 2020

Quick facts

Lead sponsor	Hacettepe University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	44
Start date	25 October 2019
Primary completion	24 September 2020
Estimated completion	24 September 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Progressive relaxation exercises

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

Hacettepe University

Who can join

Adults 30 to 70, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effects of progressive relaxation exercises on artralgia, quality of life and anxiety-deppression in breast cancer patients receiving aromatase inhibitor. Half of the participants will receive supervised progressive relaxing exercises, while other half will not receive any exercise but only advice about relaxing. Hypothesis: Progressive relaxation exercises improve the pain, quality of life and emotional status in breast cancer patients receiving aromatase inhibitor therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Progressive relaxation training in patients with breast cancer receiving aromatase inhibitor therapy-randomized controlled trial.
Bahçacı U, Atasavun Uysal S, Erdogan İyigün Z, Ordu Ç, et al · · 2024 · cited 5× · PMID 38635763 · DOI 10.1371/journal.pone.0301020

Verify or expand the search:

Other trials of Progressive relaxation exercises

Trials testing the same drug.

NCT06980558 — Effect of Progressive Muscle Exercises on Sleep in Urological Surgery · NA · recruiting
NCT06726239 — Progressive Relaxation Exercises Before Mobilization:Effects on Pain, Anxiety and Physiologic Parameters CABG Patients · NA · recruiting
NCT05591898 — The Effect of Progressive Relaxation Exercises on Bariatric Surgery Period · NA · unknown
NCT05508542 — Progressive Relaxation Exercises and Sleep, Anxiety and Stress in Risky Pregnants · NA · completed
NCT06085599 — The Effect of Exercises on Pain and Kinesiophobia in Transplant Patients · NA · completed

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04163692 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 1 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04163692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing